NEPH Nephros, Inc.
Healthcare$3.47-5.06%ClosedMarket Cap: $37.7M
As of 2026-05-25
Valuation
P/E (TTM)
24.78
PEG
0.02
P/B
3.45
P/S
1.97
EV/EBITDA
42.53
DCF Value
$-6.07
FCF Yield
-0.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
59.1%
Operating Margin
3.5%
Net Margin
4.1%
ROE
7.7%
ROA
5.6%
ROIC
5.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $5.2M | 56.9% | $97.0K | $140.0K | $— | — |
| Q4 null | $4.7M | 55.4% | $18.0K | $62.0K | $— | — |
| FY null | $18.8M | 61.1% | $1.1M | $1.2M | $— | — |
| Q3 null | $4.8M | 61.2% | $314.0K | $337.0K | $— | — |
| Q2 null | $4.4M | 63.2% | $248.0K | $237.0K | $— | — |
| Q1 null | $4.9M | 64.7% | $566.0K | $558.0K | $— | — |
| Q4 null | $3.9M | 64.0% | $317.0K | $349.0K | $— | — |
| FY null | $14.2M | 61.6% | $6.0K | $74.0K | $— | — |
| Q3 null | $3.5M | 61.1% | $206.0K | $183.0K | $— | — |
| Q2 null | $3.3M | 58.8% | $-317.0K | $-289.0K | $— | — |
| Q1 null | $3.5M | 62.1% | $-200.0K | $-169.0K | $— | — |
| Q4 2023 | $3.3M | 62.1% | $-649.0K | $-654.0K | $-0.06 | — |